Rep. Tony Wied Buys Labcorp Holdings Inc. (NYSE:LH) Stock

Rep. Tony Wied Buys Labcorp Holdings Inc. (NYSE:LH) Stock

Representative Tony Wied, a Republican from Wisconsin, disclosed the purchase of $15,001 - $50,000 of Labcorp Holdings Inc. (NYSE:LH) stock in a filing made on March 12th, 2026. The transaction, dated February 19th, 2026, was reported as Joint ownership of assets.

Tony Wied's Recent Trades

• 10/27/2025: Sold $15,001 - $50,000 of FTNT stock
• 10/27/2025: Bought $50,001 - $100,000 of HUBS stock
• 10/27/2025: Sold $15,001 - $50,000 of WAL stock
• 10/27/2025: Sold $15,001 - $50,000 of AVGO stock
• 10/27/2025: Bought $50,001 - $100,000 of ANET stock
• 10/27/2025: Bought $100,001 - $250,000 of DIS stock
• 10/27/2025: Bought $100,001 - $250,000 of FIVE stock
• 10/27/2025: Bought $50,001 - $100,000 of LCII stock
• 10/27/2025: Bought $100,001 - $250,000 of CRM stock
• 10/27/2025: Bought $100,001 - $250,000 of NOW stock

LH Stock Performance

Shares of LH opened at $270.00 on Friday, down 2.78%. The 50-day moving average is $271.36 and the 200-day moving average is $266.82. The 52-week low is $209.38 and the 52-week high is $293.72.

Since the transaction date (February 19th, 2026), LH shares have fallen 5.41%, opening at $277.94 on the transaction date. The stock rose 3.48% in the first week and fell 0.73% over two weeks.

Labcorp's debt-to-equity ratio is 0.84, the current ratio is 1.42 and the quick ratio is 1.23. Market capitalization is $21.80 billion, the trailing P/E ratio is 24.75 and beta is 0.97. Reported fiscal 2025 revenue was $13.95 billion with net income of $876,500,000 and EPS of $10.54; return on equity was 10.28% and net margin was 6.28%, representing year-over-year revenue growth of 7.25%.

Key Stories Impacting LH

• (Positive) Feb 24, 2026 — Labcorp expanded its partnership with PathAI to offer PathAI’s FDA-cleared digital pathology platform across Labcorp’s U.S. anatomical pathology labs and participating hospitals.
• (Positive) Feb 2026 — Labcorp announced a collaboration with Roche to implement the cobas Mass Spec automated mass-spectrometry platform beginning at its Burlington, NC lab.
• (Neutral) Feb 17, 2026 — Labcorp reported fourth-quarter 2025 and full-year results and issued 2026 guidance including enterprise revenue guidance and an adjusted EPS range.
• (Positive) Mar 9, 2026 — Labcorp announced a community partnership with Clemson University to provide diagnostic testing support for Clemson Rural Health mobile units and fixed clinics.
• (Neutral) Mar 2026 — The CDC announced streamlined access to commercial laboratory data, including Labcorp, into the One CDC Data Platform to support public-health surveillance.
• (Negative) Feb 17, 2026 — The stock declined about 6.6% intraday on earnings day amid investor re-pricing and mixed analyst commentary.
• (Positive) Feb–Mar 2026 — Coverage noted Labcorp’s launch of new specialty tests, including an Alzheimer’s-related assay, and its 2026 outlook as potential catalysts.

Analyst Ratings for LH

Piper Sandler reiterated a 'Neutral' rating on 2026-02-24. Baird reiterated an 'Outperform' rating on 2026-02-18. JP Morgan reiterated an 'Overweight' rating on 2026-02-18. JP Morgan reiterated an 'Overweight' rating on 2026-02-06. JP Morgan reiterated an 'Overweight' rating on 2025-11-07.

Presently, 302 analysts have rated LH with a buy recommendation, 115 have issued a hold, and 5 have given a sell rating. The average rating is 'Moderate Buy' with an average price target of $315.38.

Institutional Investors Weigh In On LH

VANGUARD GROUP INC holds 9,850,631 shares valued at $2.59 billion. BLACKROCK, INC. holds 6,540,781 shares valued at $1.72 billion. VICTORY CAPITAL MANAGEMENT INC holds 5,356,825 shares valued at $1.41 billion. STATE STREET CORP holds 3,826,327 shares valued at $1.01 billion. ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC holds 2,204,276 shares valued at $579.53 million. Currently, 95.89% of the stock is owned by institutional investors.

About Tony Wied

Representative Tony Wied is a Republican member of the U.S. House representing Wisconsin's 8th Congressional District. He has served in the House since 2024 and was born in 1976; he is 50 years old. Wied's official House website is listed in his public profile.

About LH

Labcorp Holdings Inc. is a Medical - Diagnostics & Research company that provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, NC and lists Adam H. Schechter as CEO. The profile notes an IPO date of March 29, 1990.